HYPERSENSITIVITY TO SUBSTANCE-P IN THE ETIOLOGY OF POSTLUMBAR PUNCTURE HEADACHE

被引:14
作者
SOLOMON, GD
CLARK, JW
DESENANAYAKE, P
KUNKEL, RS
机构
[1] CLEVELAND CLIN FDN,DEPT NEUROL,CLEVELAND,OH 44195
[2] CLEVELAND CLIN FDN,DEPT CARDIOVASC BIOL,CLEVELAND,OH 44195
来源
HEADACHE | 1995年 / 35卷 / 01期
关键词
D O I
10.1111/j.1526-4610.1995.hed3501025.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective.-Postlumbar puncture headache may represent a model which could be used to test the hypothesis that headache pain is caused by the release of substance P in patients who are predisposed to headache due to hypersensitivity to substance P. Methods.-We measured substance P in CSF and plasma in 37 patients undergoing diagnostic lumbar puncture. In 9 patients. plasma samples were obtained before lumbar puncture, in 28 patients plasma was obtained after lumbar puncture. Patients were followed up by telephone to determine if they developed postlumbar puncture headache. Patients were also asked about a history of chronic or recurrent headaches. Substance P was determined by radioimmunoassay. Results.-The mean plasma substance P levels obtained before lumbar puncture was 1.0 +/- 0.1 pg/mL and 1.3 +/- 1.2 after lumbar puncture (P <0.0005). The mean plasma substance P levels in subjects who developed postlumbar puncture headache was 0.6 +/- 0.6 pg/mL compared with 1.4 +/- 1.5 in subjects who remained headache-free (P<0.05). The mean CSF substance P levels in subjects who developed postlumbar puncture headache was 0.7 +/- 0.5 pg/mL compared with 1.2 +/- 0.8 in subjects who remained headache-free (P<0.05). There were no significant differences in substance P levels between chronic headache sufferers and nonheadache subjects. Conclusions.-Postlumbar puncture headache may be mediated by the release of substance P triggered by lumbar puncture. in patients predisposed to headache by a hypersensitivity to substance P. Hypersensitivity to substance P may also represent a mechanism for headache pain in other headache disorders.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 20 条
[1]   SUBSTANCE-P IN CSF OF PATIENTS WITH CHRONIC PAIN SYNDROMES [J].
ALMAY, BGL ;
JOHANSSON, F ;
VONKNORRING, L ;
LEGREVES, P ;
TERENIUS, L .
PAIN, 1988, 33 (01) :3-9
[2]  
ARAKI N, 1992, 9TH S INT MIGR TRUST
[3]  
BLEGVAD N, 1985, CEPHALALGIA S3, V5, P352
[4]   INTERACTIONS BETWEEN SEROTONIN AND SUBSTANCE-P IN THE SPINAL REGULATION OF NOCICEPTION [J].
EIDE, PK ;
HOLE, K .
BRAIN RESEARCH, 1991, 550 (02) :225-230
[5]   THE ROLE OF 5-HYDROXYTRYPTAMINE (5-HT) RECEPTOR SUBTYPES AND PLASTICITY IN THE 5-HT SYSTEMS IN THE REGULATION OF NOCICEPTIVE SENSITIVITY [J].
EIDE, PK ;
HOLE, K .
CEPHALALGIA, 1993, 13 (02) :75-85
[6]   AGONIST-INDUCED SUBSTANCE P-RECEPTOR DOWN-REGULATION IN RAT CENTRAL NERVOUS-SYSTEM [J].
INOUE, A ;
TAKEDA, R ;
FUKUYASU, T ;
NAKATA, Y ;
SEGAWA, T .
PHARMACEUTICAL RESEARCH, 1988, 5 (12) :795-799
[7]   POSTLUMBAR PUNCTURE HEADACHES - EXPERIENCE IN 501 CONSECUTIVE PROCEDURES [J].
KUNTZ, KM ;
KOKMEN, E ;
STEVENS, JC ;
MILLER, P ;
OFFORD, KP ;
HO, MM .
NEUROLOGY, 1992, 42 (10) :1884-1887
[8]   DESENSITIZATION TO INTRATHECAL SUBSTANCE-P IN MICE - POSSIBLE INVOLVEMENT OF OPIOIDS [J].
LARSON, AA .
PAIN, 1988, 32 (03) :367-374
[9]  
MARSHALL KW, 1990, ARTHRITIS RHEUM, V33, P87
[10]   RADIOIMMUNOASSAY OF SUBSTANCE-P AND ITS STABILITY IN TISSUE [J].
MCGREGOR, GP ;
BLOOM, SR .
LIFE SCIENCES, 1983, 32 (06) :655-662